UWM
LTRN icon

Urban Wealth Management’s Lantern Pharma LTRN Stock Holding History

Urban Wealth Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$14K Buy
+2,472
New +$14.7K 0.05% 178

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Urban Wealth Management's LTRN Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Lantern Pharma (LTRN) in Q2 2022: 2,472 shares worth $14K. The stake represents 0.05% of the portfolio and ranks #178 among its holdings.

26 funds tracked by Wall St. Rank hold LTRN as of Q2 2022.

  • Urban Wealth Management held 2,472 shares of Lantern Pharma worth $14K as of Q2 2022.
  • Lantern Pharma was a new Urban Wealth Management position in Q2 2022.
  • Lantern Pharma made up 0.05% of Urban Wealth Management's portfolio in Q2 2022, its #178 holding.
  • 26 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.